3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
657
INDUSTRY
393
NETWORK
82
NIH
76
OTHER_GOV
15
UNKNOWN
1
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Osteosarcoma
1
Interventions
Proflavine
4
Microbial Collagenase
2
sargramostim
1
pembrolizumab
1
pegfilgrastim
1
macimorelin
1
keyhole-limpet hemocyanin
1
Sodium Chloride
1
Sirolimus
1
Peptides
1
Monatide (IMS 3015)
1
Ipilimumab
1
Gemcitabine
1
Everolimus
1
Biological Products
1
Bimatoprost
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
INDIV
×
Gemcitabine
×
Clear all
NCT02429973
2015-04-29
GEIS-29
Broto, Javier MartÃn, M.D.
Phase 2
Completed
33 enrolled